Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery

5–10 % of breast cancer cases are hereditary, 30 % of them are caused by BRCA1 and BRCA2 mutations (breast / ovarian cancer syndrome). Average cumulative risks of breast and ovarian cancer in BRCA1 mutation carriers run up to 87 % and 44 %, correspondingly. The risk for contralateral breast cancer i...

Full description

Bibliographic Details
Main Authors:	L. N. Lyubchenko, Ye. I. Bateneva, I. K. Vorotnikov, S. M. Portnoy, O. V. Krokhina, V. A. Sobolevskiy, L. G. Zhukova, V. A. Khaylenko, S. A. Tyulyandin
Format:	Article
Language:	Russian
Published:	ABV-press 2015-06-01
Series:	Успехи молекулярной онкологии
Subjects:	hereditary breast cancer hereditary ovarian cancer brca1 brca2 mutation single nucleotide polymorphism genetic counselling genetic testing prophylactic mastectomy prophylactic oophorectomy
Online Access:	https://umo.abvpress.ru/jour/article/view/20

Similar Items

Hereditary breast cancer: present status of problem
by: F. S. Gatueva, et al.
Published: (2020-05-01)

Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries
by: Hiba A. Moukadem, et al.
Published: (2022-01-01)

Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania
by: Claudiu Ioan Filip, et al.
Published: (2024-03-01)

Pattern Anlysis of Risk-Reducing Strategies in Unaffected Korean <i>BRCA1/2</i> Mutation Carriers
by: Dabin Kim, et al.
Published: (2024-11-01)

GENETICAL ASPECTS OF SURGICAL TREATMENT IN PATIENTS WITH HEREDITARY BREAST CANCER
by: E. M. Bit-Sava
Published: (2018-01-01)

Gynecologic and breast cancers with hereditary cancer predisposition syndromes
by: Courtney F. Connelly, et al.
Published: (2024-11-01)

Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience
by: Aya Tanaka, et al.
Published: (2023-11-01)

Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014-07-01)

Oncological Safety of Lipofilling in Healthy BRCA Carriers After Bilateral Prophylactic Mastectomy: A Case Series
by: Christophe Ho Quoc, et al.
Published: (2019-10-01)

Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery
by: Daniela Luvero, et al.
Published: (2024-11-01)

Hereditary diffuse gastric cancer syndrome: medical genetic consulting, treatment strategy for family members, prophylactic total gastrectomy, and endoscopic surveillance in CDH1- and CTNNA1-mutation carriers
by: N. V. Kovalenko, et al.
Published: (2022-06-01)

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
by: Lauren C. Tindale, et al.
Published: (2022-06-01)

Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study
by: Alexandra Michel, et al.
Published: (2024-08-01)

Hereditary Breast Cancer in Romania—Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country
by: Andreea Cătană, et al.
Published: (2023-05-01)

Hereditary Women’s Cancer: Management and Risk-Reducing Surgery
by: Carmine Conte, et al.
Published: (2023-02-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing
by: Samantha Greenberg, et al.
Published: (2019-11-01)

REPARATION SYSTEM GENES: POPULATION DIFFERENCES IN HEREDITARY OVARIAN AND BREAST CANCER DETERMINED BY NEXT-GENERATION SEQUENCING
by: O. I. Brovkina, et al.
Published: (2017-06-01)

HEREDITARY MULTIPLE PRIMARY BREAST AND OVARIAN CANCER (CASE REPORT)
by: Е. V. Panferova, et al.
Published: (2016-02-01)

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
by: S. A. Laptiev, et al.
Published: (2018-06-01)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
by: Jacek Gronwald, et al.
Published: (2023-06-01)

Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya
by: Eanas Saleh Elmaihub, et al.
Published: (2024-12-01)

Management of men with high genetic risk of breast cancer. Is there a place for screening or risk-reducing surgery? Case report and review.
by: M Mouelle, et al.
Published: (2023-03-01)

BRCA2 c.8827C>T pathogenic mutation in a consanguineous Chinese family with hereditary breast cancer
by: Jiangfen Wang, et al.
Published: (2020-09-01)

Prophylactic mastectomy and hereditary breast cancer
by: Damir Grebić, et al.
Published: (2024-01-01)

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
by: Abdel-Razeq H, et al.
Published: (2023-01-01)

Genetic Testing Among Breast Cancer Patients in the Eastern Region of Saudi Arabia: Single-Center Experience
by: Ghadeer Al Ghareeb, et al.
Published: (2024-09-01)

Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
by: Felicia Adam, et al.
Published: (2023-01-01)

Patient-reported outcomes in bilateral prophylactic mastectomy with breast reconstruction: A narrative review
by: Pavla Ticha, et al.
Published: (2024-02-01)

Navigating complex choices through legitimation: Narrative strategies in risk-reduction mastectomy decision-making among unaffected women with genetic risk for breast cancer in Switzerland
by: Maria Caiata-Zufferey, et al.
Published: (2025-06-01)

Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process
by: Lucy Zhao, et al.
Published: (2024-05-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
by: K. B. Kotiv, et al.
Published: (2017-12-01)

BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis
by: Zhewen Feng, et al.
Published: (2023-08-01)

Breast magnetic resonance imaging significance for breast cancer diagnostic in women with genetic predisposition and a strong family history
by: M. S. Karpova, et al.
Published: (2014-07-01)

BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso
by: Abdou Azaque Zoure, et al.
Published: (2018-07-01)

Counselling Framework for Germline <i>BRCA1/2</i> and <i>PALB2</i> Carriers Considering Risk-Reducing Mastectomy
by: Stephanie M. Wong, et al.
Published: (2024-01-01)

Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
by: Anna Öfverholm, et al.
Published: (2023-08-01)

Perceptions of Prophylactic Mastectomy in Korea
by: Han Young Yoon, et al.
Published: (2016-01-01)

High rate of mutations in the BRCA1, BRCA2, CHEK2, NBN, and BLM genes in Russian ovarian cancer patients
by: Ye. I. Bateneva, et al.
Published: (2015-01-01)

Pathogenic Variant Profile of Hereditary Cancer Syndromes in a Vietnamese Cohort
by: Van Thuan Tran, et al.
Published: (2022-01-01)